Entrada Therapeutics, Inc. Common Stock TRDA
$5.09
+5.71%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (2 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $20.00
- Implied Upside
- +292.5%
- Price Target Range
- $17.00 – $23.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-06-08 | GuggenheimDebjit Chattopadhyay |
Maintains | Buy | $20 → $17 |
| 2026-05-08 | HC Wainwright & Co.Raghuram Selvaraju |
Downgrades | Buy → Neutral | — |
| 2026-04-06 | OppenheimerFrancois Brisebois |
Maintains | Outperform | $21 → $23 |
| 2026-02-18 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2026-02-11 | GuggenheimDebjit Chattopadhyay |
Initiates coverage on | Buy | $20 |
| 2025-05-20 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2025-03-31 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2025-02-25 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2025-02-04 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2024-12-05 | Roth MKMBoobalan Pachaiyappan |
Initiates coverage on | Buy | $29 |
| 2024-11-06 | OppenheimerFrancois Brisebois |
Maintains | Outperform | $25 → $28 |
| 2024-11-06 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $18 → $20 |
| 2024-08-26 | OppenheimerFrancois Brisebois |
Reiterates | Outperform | $25 |
| 2024-08-14 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2024-06-25 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $20 → $18 |
| 2024-03-18 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $20 |
| 2024-01-05 | OppenheimerHartaj Singh |
Initiates coverage on | Outperform | $22 |
| 2023-11-27 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $25 → $20 |
| 2023-09-22 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $25 |
| 2023-08-09 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $25 |
| 2023-08-02 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $25 |
| 2023-05-24 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $25 |
| 2023-04-03 | HC Wainwright & Co.Raghuram Selvaraju |
Initiates coverage on | Buy | $25 |
| 2022-11-08 | Goldman SachsChris Shibutani |
Maintains | Neutral | $13 → $18 |
| 2022-08-16 | Goldman SachsChris Shibutani |
Maintains | Neutral | $10 → $13 |
| 2022-05-24 | Goldman SachsChris Shibutani |
Maintains | Neutral | $22 → $10 |
| 2021-11-24 | Evercore ISI GroupJonathan Miller |
Initiates coverage on | Outperform | — |
| 2021-11-23 | Cowen & Co.Joseph Thome |
Initiates coverage on | Outperform | — |
| 2021-11-23 | Goldman SachsChris Shibutani |
Initiates coverage on | Neutral | $29 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.09
- Market Cap
- $187.67 million
- 52-Week Range
- $4.11 – $16.45
- Average Volume
- 345K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.